Susquehanna International Group
UBX

Susquehanna International Group’s Unity Biotechnology UBX Stock Holding History

Susquehanna International Group’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-56,720
Closed -$21.6K – 13937
2025
Q2 		$21.6K Sell
56,720
-6,016
-10% -$5.16K ﹤0.01% 12318
2025
Q1 		$65.2K Buy
62,736
+44,046
+236% +$79.6K ﹤0.01% 11769
2024
Q4 		$18.2K Buy
+18,690
New +$23.2K ﹤0.01% 11930
2024
Q3 		– Sell
-17,837
Closed -$26.2K – 13077
2024
Q2 		$24.1K Buy
17,837
+1,397
+8% +$2.12K ﹤0.01% 11618
2024
Q1 		$27K Buy
16,440
+482
+3% +$836 ﹤0.01% 11750
2023
Q4 		$30.8K Sell
15,958
-3,223
-17% -$5.99K ﹤0.01% 11875
2023
Q3 		$46K Buy
+19,181
New +$50.8K ﹤0.01% 11338
2023
Q2 		– Sell
-28,255
Closed -$74.6K – 13169
2023
Q1 		$46.1K Buy
+28,255
New +$113K ﹤0.01% 11729
2022
Q3 		– Sell
-4,555
Closed -$28.7K – 14152
2022
Q2 		$26K Sell
4,555
-14,235
-76% -$119K ﹤0.01% 12287
2022
Q1 		$211K Sell
18,790
-16,412
-47% -$184K ﹤0.01% 11115
2021
Q4 		$514K Buy
35,202
+12,898
+58% +$282K ﹤0.01% 9130
2021
Q3 		$669K Buy
22,304
+14,183
+175% +$500K ﹤0.01% 8635
2021
Q2 		$377K Buy
8,121
+2,046
+34% +$98.5K ﹤0.01% 10279
2021
Q1 		$365K Sell
6,075
-3,270
-35% -$223K ﹤0.01% 10191
2020
Q4 		$490K Buy
9,345
+6,827
+271% +$329K ﹤0.01% 8338
2020
Q3 		$87K Buy
2,518
+1,390
+123% +$88K ﹤0.01% 9992
2020
Q2 		$98K Sell
1,128
-1,008
-47% -$74.7K ﹤0.01% 9506
2020
Q1 		$124K Buy
+2,136
New +$135K ﹤0.01% 9168
2019
Q4 		– Sell
-1,376
Closed -$84K – 10678
2019
Q3 		$84K Sell
1,376
-369
-21% -$26.1K ﹤0.01% 9633
2019
Q2 		$166K Buy
+1,745
New +$148K ﹤0.01% 9286
2019
Q1 		– Sell
-1,092
Closed -$124K – 9875
2018
Q4 		$177K Buy
+1,092
New +$145K ﹤0.01% 7851

Other funds holding UBX

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
AWM
AllSquare Wealth Management Albany, New York $189M AUM 14.89% 1-Year Est. Return

Susquehanna International Group's UBX Position: Q3 2025 in Review

Susquehanna International Group sold out of Unity Biotechnology (UBX) in Q3 2025, closing a stake of 56,720 shares — an estimated $21.6K sold.

Susquehanna International Group first reported a position in UBX in Q4 2018 and held it in 21 quarters. The position peaked at $669K in Q3 2021. 6 funds tracked by Wall St. Rank hold UBX as of Q3 2025.

  • Susquehanna International Group reported no remaining Unity Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 56,720 Unity Biotechnology shares in Q3 2025, an estimated $21.6K.
  • Susquehanna International Group first reported a position in Unity Biotechnology in Q4 2018 and held it in 21 quarters.
  • Susquehanna International Group's Unity Biotechnology position peaked at $669K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Unity Biotechnology as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.